← Back to Search

Other

Hyperbaric oxygen therapy for Cerebral Disorders

Phase 1
Waitlist Available
Led By Paul G Harch, M.D.
Research Sponsored by Paul G. Harch, M.D.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Cerebral disorder of greater than one year's duration
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after completion of hyperbaric oxygen therapy
Awards & highlights

Study Summary

Hypothesis: That HBOT can be toxic in the low-pressure range.

Eligible Conditions
  • Cerebral Disorders

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after completion of hyperbaric oxygen therapy
This trial's timeline: 3 weeks for screening, Varies for treatment, and after completion of hyperbaric oxygen therapy for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Oxygen toxicity

Trial Design

1Treatment groups
Experimental Treatment
Group I: Hyperbaric oxygen therapyExperimental Treatment1 Intervention
Patients undergoing low pressure HBOT for chronic brain injury
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Hyperbaric oxygen therapy
2013
Completed Phase 3
~1580

Find a Location

Who is running the clinical trial?

Paul G. Harch, M.D.Lead Sponsor
4 Previous Clinical Trials
160 Total Patients Enrolled
Harch Hyperbaric Research FoundationOTHER
3 Previous Clinical Trials
130 Total Patients Enrolled
Paul G Harch, M.D.Principal InvestigatorLSU School of Medicine
4 Previous Clinical Trials
160 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby May 2025